Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Cash from Financing Activities (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Cash from Financing Activities for 2 consecutive years, with $715000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 574.53% to $715000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 381.5% year-over-year, with the annual reading at $1.1 million for FY2025, 381.5% up from the prior year.
  • Cash from Financing Activities hit $715000.0 in Q4 2025 for Connect Biopharma Holdings, up from $215000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $715000.0 in Q4 2025 to a low of $2000.0 in Q1 2025.